quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:08:35·753d
NEWSRelease
Applied Therapeutics Inc. logo
Avalo Therapeutics Inc. logo
CleanSpark Inc. logo
+16

Why Doma Holdings Shares Are Trading Higher By Around 34%; Here Are 20 Stocks Moving Premarket

APLT· Applied Therapeutics Inc.AVTX· Avalo Therapeutics Inc.CLSK· CleanSpark Inc.CURV· Torrid Holdings Inc.DOMA· Doma Holdings Inc.GRTX· Galera Therapeutics Inc.
Health CareFinanceConsumer Discretionary
Original source

Companies

  • APLT
    Applied Therapeutics Inc.
    Health Care
  • AVTX
    Avalo Therapeutics Inc.
    Health Care
  • CLSK
    CleanSpark Inc.
    Finance
  • CURV
    Torrid Holdings Inc.
    Consumer Discretionary
  • DOMA
    Doma Holdings Inc.
    Finance
  • GRTX
    Galera Therapeutics Inc.
    Health Care
  • GUTS
    Fractyl Health Inc.
    Health Care
  • MCAF
    Mountain Crest Acquisition Corp. IV
    Finance
  • MDIA
    Mediaco Holding Inc.
    Consumer Discretionary
  • NDRA
    ENDRA Life Sciences Inc.
    Health Care
  • OXM
    Oxford Industries Inc.
    Industrials
  • PAVM
    PAVmed Inc.
    Health Care
  • QLI
    Qilian International Holding Group Ltd.
    Health Care
  • SBFM
    Sunshine Biopharma Inc.
    Health Care
  • SINT
    SiNtx Technologies Inc.
    Health Care
  • VSTE
    Vast Renewables Limited
    Industrials
  • VVOS
    Vivos Therapeutics Inc.
    Health Care
  • XLO
    Xilio Therapeutics Inc.
    Health Care
  • XTKG
    X3 Holdings Co. Ltd.
    Technology

Recent analyst ratings

  • Apr 22OXMUpdateTelsey Advisory Group$51.00
  • Apr 13SINTUpdateH.C. Wainwright$10.00
  • Apr 9AVTXUpdateWolfe Research$48.00
  • Apr 6AVTXUpdateCitizens$52.00
  • Mar 27OXMUpdateTelsey Advisory Group$36.00
  • Feb 2AVTXUpdateGuggenheim$50.00

Related

  • PR1d
    Lucid Diagnostics Announces $18 Million Underwritten Offering of Common Stock
  • SEC1d
    Vivos Therapeutics Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
  • SEC2d
    SEC Form 425 filed by Galera Therapeutics Inc.
  • SEC2d
    SEC Form 425 filed by Galera Therapeutics Inc.
  • ANALYST2d
    Telsey Advisory Group reiterated coverage on Oxford Industries with a new price target
  • SEC3d
    ENDRA Life Sciences Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
  • SEC3d
    SEC Form S-3 filed by PAVmed Inc.
  • SEC3d
    SEC Form DEF 14A filed by Galera Therapeutics Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022